Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-02-18 00:00:00 ET · period of report 2022-02-16 · accession 0001209191-22-011338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-18 | 2022-02-16 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| DM | 2022-02-18 | 2022-02-16+ | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $31.69 | -8,009 | 89.8K | -8% | -$253.8K |
| D | 2022-02-18 | 2022-02-16 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $0.00 | -5,000 | 52.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | M | A | 5,000 | $1.53 | 97,777 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-16 | S | D | 5,000 | $31.54 | 92,777 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-17 | S | D | 3,009 | $31.93 | 89,768 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-02-16 | M | D | 5,000 | $0.00 | 52,591 | D | $1.53 · — to 2028-04-27 | 5,000 Common Stock | (F3) 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |